ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in BMY — Bristol Myers Squibb Co
CIK 1164508
BOSTON, MA
Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$494,716,446
-$43,417,600 QoQ
Shares Held
8,585,846
-3.2% QoQ
Ownership
0.420%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#35
of 2,514 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. BMY ranks #3 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
959,904 | $121,274,271 |
All Filings in BMY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $494,716,446 | 8,585,846 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $538,134,046 | 8,872,779 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $927,258,806 | 17,190,560 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $669,012,362 | 14,833,977 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $523,599,197 | 11,311,281 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $130,529,761 | 2,140,183 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $8,962,327 | 158,457 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $105,092,994 | 2,031,175 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $121,246,876 | 2,919,501 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $180,671,312 | 3,331,575 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $25,206,909 | 491,267 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $9,966,280 | 171,714 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $68,333,283 | 985,908 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $19,029,551 | 264,483 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $19,506,740 | 274,395 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $159,312,608 | 2,181,468 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $384,502,037 | 6,166,833 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $357,068,583 | 6,034,622 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $84,509,726 | 1,264,737 | Shares | Defined | 2021-08-13 | |
| 2020-06-30 | $64,218,302 | 1,092,148 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $122,964,613 | 2,206,039 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||